Enzolytics Inc (ENZC)

[KMC-1]

The mutual recognition agreement does not side step the bulk of the bureaucratic process for FDA approval. It simply allows some of the data to be accepted as accurate, but will still require independent verification - which could take years.
And yes, this “could” find acceptance by the European market(s) sooner, but that would require a partnership.

Clome3 is still a decade or more out.